NPI: 1902376924 · LAKEWOOD, CO 80226 · Clinical Medical Laboratory · NPI assigned 12/03/2018
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VICE PRESIDENT) |
| NPI Enumeration Date | 12/03/2018 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 16,905 | $673K |
| 2020 | 29,105 | $1.23M |
| 2021 | 110,839 | $4.29M |
| 2022 | 73,999 | $2.48M |
| 2023 | 62,292 | $1.88M |
| 2024 | 36,312 | $1.10M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 50,624 | 44,615 | $3.30M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 55,779 | 52,473 | $1.71M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 77,175 | 72,102 | $1.62M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18,804 | 17,130 | $1.36M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 31,438 | 28,636 | $953K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 31,417 | 28,615 | $953K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 10,581 | 9,912 | $316K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 14,064 | 12,509 | $290K |
| 88342 | 3,144 | 2,868 | $197K | |
| 88141 | 8,098 | 7,555 | $119K | |
| 87625 | 3,478 | 3,227 | $116K | |
| 88142 | 5,588 | 5,270 | $92K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 349 | 329 | $81K |
| 88304 | 1,660 | 1,551 | $66K | |
| 87512 | 1,231 | 1,167 | $58K | |
| 87480 | 3,048 | 2,883 | $53K | |
| 87660 | 3,030 | 2,877 | $53K | |
| 87510 | 3,043 | 2,882 | $53K | |
| 88307 | 437 | 389 | $48K | |
| 88341 | 501 | 430 | $46K | |
| 87481 | 975 | 941 | $42K | |
| 88312 | 853 | 776 | $40K | |
| 85060 | 2,128 | 2,049 | $35K | |
| 87799 | 363 | 345 | $27K | |
| 87150 | 432 | 419 | $15K | |
| 88112 | 242 | 206 | $11K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 463 | 457 | $6K |
| 87081 | 430 | 417 | $3K | |
| 87529 | 51 | 49 | $2K | |
| 88313 | 26 | 25 | $374.00 |